Table 1.
Study | Smiddy et al.6 | Pathengay et al.7 | Chhlabani et al.4 | Mohan et al.8 |
---|---|---|---|---|
Years | 1985–1991 | 1992–2002 | 2003–2012 | 2007–2012 |
Number of buckles analyzed | 45 | 73 | 51 | 25 |
Location | Miami | India | India | India |
Culture Positivity Rate, % | 73.3 | 83.3 | 78.3 | 83.33 |
Most common culture isolate, % | Coagulase-negative Staph (52) | Coagulase-negative Staph (27.4) | Gram negative bacteria (25) | Atypicala mycobacteria (23.8) |
Atypicala mycobacteria, % | 18 | 20.5 | 18 | 23.8 |
Fungal isolates, % | 2.3 | 15.1 | 16 | 19 |
Polymycrobial infection, % | 32.7 | 21.1 | 7.8 | 5 |
Suggested first-line treatment | Vancomycin, Aminoglycoside | Vancomycin, Ciprofloxacin, Amikacin | Vancomycin, Ciprofloxacin, Amikacin | Vancomycin, Amikacin |
Atypical mycobacteria: Acid-fast mycobacteria that do not cause tuberculosis nor leprosy.